Concepedia

Chi-Hung R. Or

CR

Statistics

Publications

4

Citations

120

H-Index

4

Active since

2016

Affiliations

National Chung Hsing University(Current)

China Medical University Hospital

Asia University

China Medical University

Kuang Tien General Hospital

Chi-Hung R. Or is an author at National Chung Hsing University specializing in apoptosis, oncology, and molecular oncology.

Publications per year

2016–2020

4

Publications

4

Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling

Chi-Hung R. Or, Chiao-Wen Huang, Ching-Chin Chang et al. · International Journal of Molecular Sciences · 2020 · 50 citations · Full text

, , +17

Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4′-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells

Yen-Po Cheng, Shiming Li, Wan-Ling Chuang et al. · International Journal of Molecular Sciences · 2019 · 32 citations · Full text

, , +17

Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells

Chi-Hung R. Or, Ya‐Chu Chang, Wei‐Cheng Lin et al. · International Journal of Molecular Sciences · 2016 · 24 citations · Full text

, , +17

Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo

Chi-Hung R. Or, Hong-Lin Su, Wee-Chyan Lee et al. · Oncology Reports · 2016 · 14 citations · Full text

, , +11

1–4 of 4